Endovasc, Inc. is an early-stage drug development company that creates new cardiovascular and metabolic drug therapies. The Company's products are designed to deliver and release drugs to their intended targets in an efficient and controlled manner. Endovasc's lead drug candidates include stent-coating technology, biodegradable stents, and other drug-delivery stents.
550 Club Drive
Montgomery, TX 77316